Updates are available Correction dated 2022-01-02
Click to view Correction: https://doi.org/10.1038/s41592-021-01379-x
-
Authors
Xu, Chunlong
Zhou, Yingsi
Xiao, Qingquan
He, Bingbing http://orcid.org/0000-0002-9790-8087
Geng, Guannan
Wang, Zikang
Cao, Birong
Dong, Xue
Bai, Weiya
Wang, Yifan
Wang, Xiang
Zhou, Dongming
Yuan, Tanglong http://orcid.org/0000-0003-4670-2625
Huo, Xiaona
Lai, Jinsheng http://orcid.org/0000-0001-9202-9641
Yang, Hui http://orcid.org/0000-0003-3590-722X
- License Information
-
More Information
Article History
Received: 14 May 2020
Accepted: 18 March 2021
First Online: 3 May 2021
Change Date: 2 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41592-021-01379-x
Competing interests
: H.Y. is a founder of Hui-Gene Therapeutics. H.Y., C.X., Y.Z., and Q.X. are co-inventors on US patent application 16/864,982 relating to the Cas proteins described in this manuscript. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.
